Delavirdine mesylate

Catalog No.S6452

For research use only.

Delavirdine Mesylate is a mesylate salt form of delavirdine, which is a synthetic, non-nucleoside reverse transcriptase inhibitor.

Delavirdine mesylate Chemical Structure

CAS No. 147221-93-0

Selleck's Delavirdine mesylate has been cited by 1 Publication

Purity & Quality Control

Choose Selective Reverse Transcriptase Inhibitors

Other Reverse Transcriptase Products

Biological Activity

Description Delavirdine Mesylate is a mesylate salt form of delavirdine, which is a synthetic, non-nucleoside reverse transcriptase inhibitor.
Targets
HIV1 RT [1]
0.26 μM
In vitro

Delavirdine is a potent and selective inhibitor of the HIV-1 RT (IC50=0.26 μM verus IC50s>440 μM for pol alpha and delta). Delavirdine has low cellular cytotoxicity, causing less than 8% reduction in human lymphocyte viability at 100 μM[1].

In vivo

Following single dose administration, the pharmacokinetics of delavirdine is nonlinear in rats, and appeared to be nonlinear in dogs. Systemic clearances in the dog, at a dose of 10 mg/kg, are approximately 20-fold lower than in the rat, whereas the clearances in monkeys are comparable to those in rats. Absolute p.o. bioavailabilities increase in the order monkey (30%) < rat (65%) < dog (100%) when equivalent i.v. and p.o. doses are administered[1].

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 552.67
Formula

C23H32N6O6S2

CAS No. 147221-93-0
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C.CS(=O)(=O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Delavirdine mesylate | Delavirdine mesylate supplier | purchase Delavirdine mesylate | Delavirdine mesylate cost | Delavirdine mesylate manufacturer | order Delavirdine mesylate | Delavirdine mesylate distributor